Transcranial activation and imaging of low boiling point phase‐change contrast agents through the temporal bone using an ultrafast interframe activation ultrasound …

B Jing, EP Kashyap, BD Lindsey - Medical Physics, 2020 - Wiley Online Library
Purpose As a cavitation enhancer, low boiling point phase‐change contrast agents (PCCA)
offer potential for ultrasound‐mediated drug delivery in applications including intracerebral …
被引用次数：10 相关文章

Transcranial activation and imaging of low boiling point phase-change contrast agents through the temporal bone using an ultrafast interframe activation ultrasound …

B Jing, EP Kashyap, BD Lindsey - Medical physics, 2020 - pubmed.ncbi.nlm.nih.gov
Purpose As a cavitation enhancer, low boiling point phase-change contrast agents (PCCA)
offer potential for ultrasound-mediated drug delivery in applications including intracerebral …

Transcranial activation and imaging of low boiling point phase-change contrast agents through the temporal bone using an ultrafast interframe activation ultrasound …

B Jing, EP Kashyap, BD Lindsey - Medical Physics, 2020 - europepmc.org
Purpose As a cavitation enhancer, low boiling point phase-change contrast agents (PCCA)
offer potential for ultrasound-mediated drug delivery in applications including intracerebral …

Transcranial activation and imaging of low boiling point phase-change contrast agents through the temporal bone using an ultrafast interframe activation ultrasound …

B Jing, EP Kashyap, BD Lindsey - Medical Physics, 2020 - ui.adsabs.harvard.edu
PurposeAs a cavitation enhancer, low boiling point phase-change contrast agents (PCCA)
offer potential for ultrasound-mediated drug delivery in applications including intracerebral …

Transcranial activation and imaging of low boiling point phase-change contrast agents through the temporal bone using an ultrafast interframe activation ultrasound …

B Jing, EP Kashyap, BD Lindsey - Medical Physics, 2020 - hero.epa.gov
Purpose: As a cavitation enhancer, low boiling point phase-change contrast agents (PCCA)
offer potential for ultrasound-mediated drug delivery in applications including intracerebral …